Fund shareholders of PTC Therapeutics Inc
ISIN US69366J2006 · United States · LEI 549300UJLWOIWFDGB318
- Fund shareholders
- 407
- Of which ETFs
- 98 309 other funds
- Value held
- 2.5B $ 16.4M SEK
- Share of capital
- 45.1 % of 83.5M shares on Jul 29, 2026
407 funds hold this company. This table lists the 404 that declare it in a regulatory filing. The other 3 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 24 | 1.6K $ | 0.15 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 20 | 1.4K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| FIIG STOCK FUND FOR RETIREMENT Unified Series Trust | 15 | 1K $ | 0.26 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Gotham 1000 Value ETF Tidal Trust I | 4 | 272.5 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Neuroscience and Healthcare ETF iShares Trust | 3.69 % | as of Apr 30, 2026 ↗ |
| Invesco S&P SmallCap Health Care ETF Invesco Exchange-Traded Fund Trust II | 3.26 % | as of Feb 28, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 2.68 % | as of Apr 30, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 2.58 % | as of Sep 30, 2025 ↗ |
| WPG Partners Select Small Cap Value Fund RBB Fund, Inc. | 2.49 % | as of Feb 28, 2026 ↗ |
| Pinnacle Focused Opportunities ETF Tidal Trust II | 2.13 % | as of Feb 28, 2026 ↗ |
| Guardian Small Cap Value Diversified VIP Fund Guardian Variable Products Trust | 2.08 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 2.01 % | as of Apr 30, 2026 ↗ |
| WPG Partners Small Cap Value Diversified Fund RBB Fund, Inc. | 1.69 % | as of Feb 28, 2026 ↗ |
| Franklin Genomic Advancements ETF Franklin Templeton ETF Trust | 1.48 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 403 | +23 | 37,646,143 | +6.3 % |
| 2026Q1 | 380 | +59 | 35,414,088 | +30.6 % |
| 2025Q4 | 321 | -3 | 27,114,754 | -3.6 % |
| 2025Q3 | 324 | +35 | 28,136,472 | +5.8 % |
| 2025Q2 | 289 | +24 | 26,588,373 | +3.5 % |
| 2025Q1 | 265 | +21 | 25,690,343 | -5.1 % |
| 2024Q4 | 244 | +13 | 27,058,700 | -6.8 % |
| 2024Q3 | 231 | -5 | 29,047,120 | -7.8 % |
| 2024Q2 | 236 | +1 | 31,519,488 | +14.3 % |
| 2024Q1 | 235 | -44 | 27,586,614 | -21.3 % |
| 2023Q4 | 279 | 35,067,475 |
Institutional managers
340 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 12,948,717 | 882.2M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 7,746,415 | 527.8M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 7,193,433 | 490M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,346,519 | 296.1M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 3,942,610 | 268.6M $ | as of Mar 31, 2026 |
| TORONTO DOMINION BANK | 3,025,963 | 206.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,209,954 | 150.6M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 2,074,449 | 141.3M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,886,841 | 128.6M $ | as of Mar 31, 2026 |
| Hood River Capital Management LLC | 1,664,559 | 113.4M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,640,381 | 111.8M $ | as of Mar 31, 2026 |
| FMR LLC | 1,528,362 | 104.1M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | 102.2M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,364,768 | 93M $ | as of Mar 31, 2026 |
| Jefferies Financial Group Inc. | 1,354,459 | 92.3M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 1,183,720 | 80.1M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 1,121,388 | 76.4M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 1,015,772 | 69.2M $ | as of Mar 31, 2026 |
| Palo Alto Investors LP | 921,607 | 62.8M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 920,476 | 62.7M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 890,715 | 60.7M $ | as of Mar 31, 2026 |
| SG Americas Securities, LLC | 879,701 | 59.9K $ | as of Mar 31, 2026 |
| Invesco Ltd. | 865,451 | 59M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 827,631 | 56.4M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 806,276 | 54.9M $ | as of Mar 31, 2026 |
Declared shareholders of PTC Therapeutics Inc
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 8.70 % | 7,193,433 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Portfolio Management | 5.88 % | 4,871,329 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 5.17 % | 4,284,448 | as of Mar 31, 2026 · SCHEDULE 13G |
| The Toronto-Dominion Bank | 3.70 % | 3,025,945 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of PTC Therapeutics Inc
10 funds declare 10 bond lines of this company. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
| Fund | Bond lines | Value | |
|---|---|---|---|
| Franklin Convertible Securities Fund | 1 | 61M $ | as of Apr 30, 2026 |
| iShares Convertible Bond ETF | 1 | 6.1M $ | as of Apr 30, 2026 |
| Fidelity Convertible Securities Fund | 1 | 2.3M $ | as of Feb 28, 2026 |
| JNL Multi-Manager Alternative Fund | 1 | 2.1M $ | as of Mar 31, 2026 |
| Fidelity Strategic Dividend and Income Fund | 1 | 987K $ | as of Feb 28, 2026 |
| Franklin Alternative Strategies Fund | 1 | 856.9K $ | as of Feb 27, 2026 |
| PACE Alternative Strategies Investments | 1 | 828.1K $ | as of Apr 30, 2026 |
| Lord Abbett Convertible Fund | 1 | 711.8K $ | as of Feb 28, 2026 |
| First Trust SSI Strategic Convertible Securities ETF | 1 | 428.2K $ | as of Apr 30, 2026 |
| Calamos Convertible Equity Alternative ETF | 1 | 47.1K $ | as of Apr 30, 2026 |
Cite this page
Titelia. "Fund shareholders of PTC Therapeutics Inc". https://titelia.com/en/stocks/ptc-therapeutics-inc-US69366J2006